Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Outbreaks of rain will move slowly from north to west but otherwise a mainly dry day ahead.
The president-elect said it was important the US improve relations with Beijing, and then immediately criticised China's economic policies.
Tory candidate Caroline Johnson wins vote ahead of Ukip in poll triggered by the resignation of Conservative MP Stephen Phillips.